E
EyeYon Medical
Health Tech & Medtech · Jerusalem, Israel · Founded 2011
Develops and brings to market exclusive medical ophthalmic devices, which offer relief to the unmet clinical needs of millions of patients MoreLess
EyeYon Medical is a pioneering company in the field of ophthalmology, specializing in the development and commercialization of innovative therapeutic contact lenses. The company's flagship product, the Hyper-CL lens, is designed to treat corneal edema and other ocular conditions, significantly improving visual acuity for patients. EyeYon Medical operates in the medical device market, primarily serving ophthalmologists and their patients in Europe and the USA, where the product is CE certified and FDA 510k cleared. The business model revolves around the sale of these specialized lenses to healthcare providers and clinics, generating revenue through direct sales and distribution partnerships. The company focuses on providing effective, non-invasive solutions for eye care, aiming to enhance patient quality of life and satisfaction.
Keywords: ophthalmology, therapeutic lenses, corneal edema, visual acuity, medical device, CE certified, FDA cleared, non-invasive, patient outcomes, healthcare providers.
Company overview
EyeYon Medical company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2011
- Headquarters
- Jerusalem, Israel
- Employees
- 27
- Open positions
- None listed
- Dealroom signal
- 63.4
Valuation & funding
EyeYon Medical funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | Mar 2021 | $25M | $100M | Rimonci Capital · Diamond BioFund · British Patient Capital · CR-CP Life Science Fund | — |
| SERIES B✓Equity / VC | Mar 2017 | $7.2M | $29M | Pontifax Funds · TriVentures · Rimonci Capital · Gauss Medical | ↗ |
| EARLY VC✓Equity / VC | Apr 2015 | $3.6M | $14M | TriVentures · Pontifax Funds | — |
| SEED✓Equity / VC | Jan 2012 | $1M | $4M | Undisclosed | — |
| SPINOUT✓Other financing | May 2011 | $0 | — | The Hebrew University of Jerusalem · Weizmann Institute of Science · Clarity Health Services | — |
| SEED✓Equity / VC | Jan 2011 | Undisclosed | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 28 |
| 2025 | 30 |
| 2024 | 29 |
| 2023 | 27 |
| 2022 | 24 |
| 2021 | 18 |
Growth signals
EyeYon Medical website traffic
Latest recorded traffic for EyeYon Medical is 3.2K monthly website visits, up 23.1% over the last three months. EyeYon Medical's team declined 10% over the past year.
Comparisons
EyeYon Medical compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
EyeYon Medical's talent
Source: Dealroom Talent Intelligence.
Investors
13 investors on EyeYon Medical's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where EyeYon Medical has talent and traffic
team presence
In the news
Latest news about EyeYon Medical
Recent press, funding announcements, and product moves mentioning EyeYon Medical — open to read from the original sources.
Market sentiment
What the market is saying about EyeYon Medical
An AI-synthesized read of the highest-engagement posts about EyeYon Medical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See EyeYon Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.